Marc Grasso
2020
Compensation breakdown
Non-Equity Incentive Plan | $257,300 |
---|---|
Option Awards | $873,160 |
Salary | $415,000 |
Other | $43,648 |
Total | $1,589,108 |
Grasso received $873.2K in option awards, accounting for 55% of the total pay in 2020.
Grasso also received $257.3K in non-equity incentive plan, $415K in salary and $43.6K in other compensation.
Rankings
In 2020, Marc Grasso's compensation ranked 6,586th out of 13,090 executives tracked by ExecPay. In other words, Grasso earned more than 49.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,586 | 50th |
Manufacturing | 2,731 | 51st |
Chemicals And Allied Products | 1,100 | 51st |
Drugs | 954 | 51st |
Pharmaceutical Preparations | 713 | 51st |
Pay ratio
Marc Grasso's Pay | $1,589,108 |
---|---|
Median Employee's Pay | $346,674 |
Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Marc Grasso was $1,589,108.
The annual total compensation of the median employee at Kura Oncology was $346,674.
The ratio of Marc Grasso's pay to the pay of median employee was therefore 5 to one.
Grasso's colleagues
We found five more compensation records of executives who worked with Marc Grasso at Kura Oncology in 2020.